MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling
Rett syndrome (RTT) is an X-linked, neurodevelopmental disorder caused primarily by
mutations in the methyl-CpG-binding protein 2 (MECP2) gene, which encodes a …
mutations in the methyl-CpG-binding protein 2 (MECP2) gene, which encodes a …
Genome-wide analysis reveals methyl-CpG–binding protein 2–dependent regulation of microRNAs in a mouse model of Rett syndrome
H Wu, J Tao, PJ Chen, A Shahab… - Proceedings of the …, 2010 - National Acad Sciences
MicroRNAs (miRNAs) are a class of small, noncoding RNAs that function as
posttranscriptional regulators of gene expression. Many miRNAs are expressed in the …
posttranscriptional regulators of gene expression. Many miRNAs are expressed in the …
Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome
RG Urdinguio, AF Fernandez, P Lopez-Nieva… - Epigenetics, 2010 - Taylor & Francis
MicroRNAs (miRNAs) are short non-coding RNA molecules that regulate post-transcriptional
gene expression. They influence a wide range of physiological functions, including neuronal …
gene expression. They influence a wide range of physiological functions, including neuronal …
Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model
Mecp2 is a transcriptional repressor protein that is mutated in Rett syndrome, a
neurodevelopmental disorder that is the second most common cause of mental retardation …
neurodevelopmental disorder that is the second most common cause of mental retardation …
[PDF][PDF] miR-199a links MeCP2 with mTOR signaling and its dysregulation leads to Rett syndrome phenotypes
K Tsujimura, K Irie, H Nakashima, Y Egashira, Y Fukao… - Cell reports, 2015 - cell.com
Rett syndrome (RTT) is a neurodevelopmental disorder caused by MECP2 mutations.
Although emerging evidence suggests that MeCP2 deficiency is associated with …
Although emerging evidence suggests that MeCP2 deficiency is associated with …
[HTML][HTML] Role of DNA methyl-CpG-binding protein MeCP2 in Rett syndrome pathobiology and mechanism of disease
S Pejhan, M Rastegar - Biomolecules, 2021 - mdpi.com
Rett Syndrome (RTT) is a severe, rare, and progressive developmental disorder with
patients displaying neurological regression and autism spectrum features. The affected …
patients displaying neurological regression and autism spectrum features. The affected …
[HTML][HTML] Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets
CR Jordan, HH Li, HC Kwan, U Francke - BMC medical genetics, 2007 - Springer
Abstract Background MeCP2, methyl-CpG-binding protein 2, binds to methylated cytosines
at CpG dinucleotides, as well as to unmethylated DNA, and affects chromatin condensation …
at CpG dinucleotides, as well as to unmethylated DNA, and affects chromatin condensation …
[PDF][PDF] The story of Rett syndrome: from clinic to neurobiology
M Chahrour, HY Zoghbi - Neuron, 2007 - cell.com
The postnatal neurodevelopmental disorder Rett syndrome (RTT) is caused by mutations in
the gene encoding methyl-CpG binding protein 2 (MeCP2), a transcriptional repressor …
the gene encoding methyl-CpG binding protein 2 (MeCP2), a transcriptional repressor …
[PDF][PDF] MECP2 is post-transcriptionally regulated during human neurodevelopment by combinatorial action of RNA-binding proteins and miRNAs
A progressive increase in MECP2 protein levels is a crucial and precisely regulated event
during neurodevelopment, but the underlying mechanism is unclear. We report that MECP2 …
during neurodevelopment, but the underlying mechanism is unclear. We report that MECP2 …
Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p
Proper neurological function in humans requires precise control of levels of the epigenetic
regulator methyl CpG-binding protein 2 (MeCP2). MeCP2 protein levels are low in fetal …
regulator methyl CpG-binding protein 2 (MeCP2). MeCP2 protein levels are low in fetal …